Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Molecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.

Knee with osteoarthritis © Shutterstock
Changes found in the knee joint fluid during surgical joint distraction may explain cartilage repair

It is generally accepted that cartilage is not able to heal or regenerate itself after injury or through wear and tear, leading to the development of osteoarthritis. But there is a body of evidence emerging that challenges this view.

Recent studies show evidence of cartilage regeneration following a surgical procedure called joint distraction. A research team from the Centre for Osteoarthritis Pathogenesis, Versus Arthritis within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) set out, in collaboration with partners in the Netherlands, to investigate whether there were molecular changes within the environment of the knee joint that could explain the repair.

The team studied a group of 20 individuals with osteoarthritis undergoing knee joint distraction, an intervention that uses an external frame fixed to both sides of the joint to gradually pull apart the knee by 5mm over 6 weeks. A benefit of the treatment, which is not yet offered in the UK, is that it takes pressure off the joint while enabling the patient to continue to walk on the leg. Knee joint distraction has previously been shown in clinical studies by the Netherlands group not only to lead to sustained improvements in knee symptoms but also to repair cartilage as measured by magnetic resonance imaging.

"It's something that goes against the dogma because people think that once the cartilage is gone that's it," said Fiona Watt, Associate Professor at NDORMS. "We were interested to know whether this intervention was changing the joint environment to promote cartilage regrowth, and if we could measure markers which might represent repair pathways. Identifying such pathways might help us to develop new treatments to prevent or delay knee arthroplasty or to treat osteoarthritis in other joints in the future, as well as understanding how this particular intervention brings about benefit."

A small sample of joint fluid was taken from each patient when the knee distraction frame was fitted, at the mid-point of distraction, and at six weeks, the point at which the distractor was removed. Patients were followed for a year in total and their osteoarthritis symptoms assessed. The team looked for changes in a panel of ten markers, previously identified as important in the response to joint injury and in repair, to determine whether any changes in the fluid could be linked to response to intervention and clinical improvement.

Change in TGFß during distractionChange in TGFß during distraction

"Several markers changed with distraction, but two markers, FGF2 and TGFß, showed a significant increase in the joint during distraction and predicted a good clinical outcome," said Professor Tonia Vincent, Director of the Centre for OA Pathogenesis at NDORMS. "Both of these are growth factors that are associated with cartilage repair in laboratory studies. Although ours was a small exploratory study, it shows that the biology in the joint changes rapidly when mechanical stress is altered and this likely facilitates cartilage repair. Identifying the molecules that drive the intrinsic power of cartilage to repair may help us to identify new molecular treatments for osteoarthritis.


Change in FGF-2 during distractionChange in FGF-2 during distraction

Caroline Aylott, Head of Research Delivery at Versus Arthritis says, “This work by our Centre for Osteoarthritis Pathogenesis is important in helping us to understand the biological processes at work when the body is trying to repair damage to cartilage. By understanding the chemical signals involved, we may, in the future be able to develop treatments to help repair cartilage and reduce the need for joint replacements.”

Published in Osteoarthritis Research Society International, the study was supported by Versus Arthritis, ReumaNederlands, the Dutch Arthritis Society, and by the NIHR Oxford Biomedical Research Centre (BRC).

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.